Bal Pharma Ltd

NSE: BALPHARMA · BSE: 524824 · Pharmaceuticals & Biotechnology · 32 announcements

Share price: ₹97.50
Market cap: ₹155.2 Cr
Revenue (annual): ₹311.7 Cr
Net profit (annual): ₹6.28 Cr
P/E (TTM): 21.5×Sector 47.4×
Promoter holding: 50.86%+0.00% QoQ
FII holding: 0.15%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 3 Annual General Meeting 3 Other Announcement 2 Management Change 2 Price Movement Clarification 1 Merger & Restructuring 1 Financial Results 1 Dividend 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

12 Aug 2026 18:37 IST NSE

Merger & Restructuring

Bal Pharma Merger & Restructuring

Bal Pharma is incorporating a new Joint Venture in the Philippines to distribute pharmaceutical products. The company will hold a 65% equity stake in this entity.

Read the filing ↗